FY2025 · ended Oct 31, 2025 · Revenue $6.95B, +6.7% YoY · Filed Dec 22, 2025
Agilent Technologies, Inc. (A) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Oct 31, 2025, it reported revenue of $6.9 billion and net income of $1.3 billion. Free cash flow was $1.2 billion. As of Jul 31, 2026 it held $1.9 billion in cash and investments and $4.1 billion in total debt.
Revenue (TTM)
$7.37B
+8.6% vs year-ago TTM
Net income (TTM)
$1.44B
+18.0% vs year-ago TTM
Operating cash flow (TTM)
$1.61B
+7.6% vs year-ago TTM
Free cash flow (TTM)
$1.27B
+16.5% vs year-ago TTM
EPS (TTM)
$5.08
+18.7% vs year-ago TTM
Dividend per share (TTM)
$1.01
+3.4% vs year-ago TTM
Shares outstanding
283.50M
-0.7% vs prior year
Net cash
$-2.26B
as of Jul 31, 2026
Operating margin
22.2%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- A (NYSE)
- Fiscal year ends
- October 31
- Incorporated in
- DE
- Headquarters
- Santa Clara, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1090872
- Former names
- AGILENT TECHNOLOGIES INC (until Sep 16, 2019)
Other Laboratory Analytical Instruments companies
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Oct 31, 2025 |
FY 2024 Oct 31, 2024 |
FY 2023 Oct 31, 2023 |
FY 2022 Oct 31, 2022 |
FY 2021 Oct 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $6.9B | $6.5B | $6.8B | $6.8B | $6.3B |
| Operating income | $1.5B | $1.5B | $1.4B | $1.6B | $1.3B |
| Net income | $1.3B | $1.3B | $1.2B | $1.3B | — |
| Diluted EPS | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
| Operating cash flow | $1.6B | $1.8B | $1.8B | $1.3B | $1.5B |
| Free cash flow | $1.2B | $1.4B | $1.5B | $1.0B | $1.3B |
| Total assets | $12.7B | $11.8B | $10.8B | $10.5B | $10.7B |
| Total liabilities | $6.0B | $5.9B | $4.9B | $5.2B | $5.3B |
| Stockholders' equity | $6.7B | $5.9B | $5.8B | $5.3B | $5.4B |
| Cash and investments | $1.9B | $1.5B | $1.8B | $1.2B | $1.7B |
| Total debt | $3.5B | $3.6B | $2.9B | $2.9B | $2.9B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 2, 2026 |
| 10-Q | Quarterly report | Sep 1, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 26, 2026 | Aug 26, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 25, 2026 | Jun 25, 2026 |
| 10-Q | Quarterly report | Jun 1, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 27, 2026 | May 20, 2026 |
All 1001 Agilent Technologies, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.